M&T Bank Corp Acquires 5,205 Shares of Acadia Healthcare Company Inc (NASDAQ:ACHC)

Share on StockTwits

M&T Bank Corp raised its holdings in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 33.6% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 20,680 shares of the company’s stock after acquiring an additional 5,205 shares during the quarter. M&T Bank Corp’s holdings in Acadia Healthcare were worth $723,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of ACHC. Geode Capital Management LLC increased its position in shares of Acadia Healthcare by 6.4% in the fourth quarter. Geode Capital Management LLC now owns 926,057 shares of the company’s stock worth $23,808,000 after purchasing an additional 56,110 shares during the last quarter. BNP Paribas Arbitrage SA increased its holdings in shares of Acadia Healthcare by 228.7% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,806 shares of the company’s stock worth $141,000 after buying an additional 3,344 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Acadia Healthcare by 4.3% during the 1st quarter. SG Americas Securities LLC now owns 8,983 shares of the company’s stock valued at $263,000 after buying an additional 368 shares in the last quarter. Texas Permanent School Fund raised its position in shares of Acadia Healthcare by 4.0% during the 1st quarter. Texas Permanent School Fund now owns 60,060 shares of the company’s stock valued at $1,760,000 after buying an additional 2,306 shares in the last quarter. Finally, Bbva Compass Bancshares Inc. bought a new stake in shares of Acadia Healthcare during the 1st quarter worth $214,000.

Shares of ACHC traded up $0.97 during trading hours on Wednesday, hitting $31.40. The company had a trading volume of 22,189 shares, compared to its average volume of 690,942. The firm has a market cap of $2.56 billion, a P/E ratio of 13.98, a P/E/G ratio of 1.28 and a beta of 0.71. The stock’s 50 day moving average price is $28.50 and its 200 day moving average price is $30.92. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.53. Acadia Healthcare Company Inc has a 52-week low of $24.27 and a 52-week high of $45.35.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, July 30th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.02. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. The company had revenue of $789.00 million during the quarter, compared to analysts’ expectations of $795.31 million. During the same period in the prior year, the business posted $0.70 EPS. Acadia Healthcare’s quarterly revenue was up 3.0% compared to the same quarter last year. On average, research analysts expect that Acadia Healthcare Company Inc will post 2.14 EPS for the current fiscal year.

In related news, CEO Debra K. Osteen acquired 20,000 shares of the stock in a transaction on Thursday, September 5th. The stock was purchased at an average price of $26.53 per share, for a total transaction of $530,600.00. Following the completion of the transaction, the chief executive officer now owns 117,178 shares of the company’s stock, valued at approximately $3,108,732.34. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.60% of the company’s stock.

Several equities research analysts have issued reports on the company. UBS Group dropped their price target on Acadia Healthcare from $30.00 to $29.00 and set a “neutral” rating for the company in a research note on Friday, September 6th. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective on the stock. in a research report on Wednesday, August 7th. TheStreet upgraded Acadia Healthcare from a “d+” rating to a “c” rating in a research report on Monday, June 17th. Raymond James cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 price objective on the stock. in a report on Wednesday, July 31st. Finally, BidaskClub upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Wednesday. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $36.00.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Further Reading: What is a bull market?

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.